SEP 08, 2020 9:00 AM PDT

Advancing Toward Personalized Medicine in Lung Cancer: A Focus on Gene Rearrangement Testing

Speaker

Abstract
Date:  September 8, 2020
Time: 8:00am PDT,  11:00am EDT
 
Advances in genomics and molecular biomarker testing have led to tremendous improvements, ushering in a new era of personalized medicine especially in the oncology practice. Many of these biomarkers have been identified as receptor tyrosine kinases, shown to be involved in the signaling pathways associated with tumor growth and development. More interesting is that a subset of the genetic alterations observed in these biomarkers are gene rearrangements that result in constitutively activated tyrosine kinases, thus providing targets for therapies that could effectively inhibit the tyrosine kinase activity. Non-small cell lung cancer patients have benefited considerably, from these advances in targeted therapies, as there are already several therapeutics to which patients positive for specific gene rearrangements have shown remarkable response. Identifying such rearrangements is becoming part of the preliminary standard of care when diagnosing non-small cell lung cancer. Various diagnostic assays have been developed to provide such information. This webinar will review the available molecular methodologies for identifying gene rearrangements specifically focusing on ALK and ROS1 gene rearrangement testing in non-small cell lung cancer. Included in the review will be an overview of the technology, the current recommendations, common practices and challenges associated with these methodologies, to better understand the available options in order to choose the best course of action throughout the patient treatment cycle.
 
Learning Objectives
  • Review functionality of gene rearrangements
  • Overview of various methodologies for identifying gene rearrangements
  • Review of the guidelines, recommendations, common practices and difficulties associated with gene rearrangement testing
  • Considerations for the best course of action throughout the patient treatment cycle
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
APR 21, 2021 5:00 PM CEST
APR 21, 2021 5:00 PM CEST
Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
Loading Comments...
Show Resources